Research Progress in the Neurovascular Unit Impairment and Treatment of Diabetic Retinopathy
DOI:
https://doi.org/10.53469/jcmp.2024.06(12).12Keywords:
Neurovascular unit impairment, Treatment, Diabetic retinopathyAbstract
Diabetic retinopathy (DR) is one of the common complications of diabetes and is a leading cause of blindness. Traditionally, DR was considered primarily a microvascular disease. However, with the progress of research, it is now believed that damage to the neurovascular unit plays a key role in the early stages of DR. An updated understanding of neurovascular unit damage facilitates early intervention of retinal function and control of DR progression. This article summarizes the latest understanding of neurovascular unit damage in DR and the latest methods for treating DR, and looks forward to more new treatment strategies in the future.
References
ZHANG Fengjun, LI Jingming, LIU Qiuping. Pathogenesis and potential treatment of diabetic retinopathy [J]. Recent Advances in Ophthalmology, 2020, 40(07):677-685.
LIU Qiuping, LIU Zhaolin, LI Jingming. Latest research advances in pathogenesis and potential therapeutic targets of diabetic retinopathy [J]. Recent Advances in Ophthalmology, 2024, 44(10):757-768.
Bao-Hua Li, Chao-Hong Guo, Cheng-Wei Guo. Research progress in the prevention and treatment of diabetic retinopathy based on retinal neurovascular unit damage and its coupling imbalance [J]. International Eye Science, 2022, 22(8):1309-1312.
Dan-Dan Chen, Tian-Jiao Shuai, Juan Li, Xiao-Hang Sun, Rui-Ying Wang, Tian-Hua Piao. Research progress on the pathogenesis of microvascular neuropathy in diabetic retinopathy [J]. International Eye Science, 2018, 18(5):844-846.
YUAN Man, JIN Wei, HAO Xinlei, YANG Anhuai. Research advances in the pathogenesis of neurovascular injury in diabetic retinopathy [J]. Recent Advances in Ophthalmology, 2020, 40(9):885-888.
PETZOLD G C, MURTHY V N. Role of astrocytes in neurovascular coupling [J]. Neuron, 2011, 71(5):782-797.
FILOSA J A, MORRISON H W, IDDINGS J A, DU W, KIM K J. Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tone [J]. Neuroscience. 2016, 323:96-109.
Roy S, Kim D. Retinal capillary basement membrane thickening: role in the pathogenesis of diabetic retinopathy [J]. Prog Retin Eye Res, 2021, 82:100903.
SCHAFER D P, LEHRMAN E K, KAUTZMAN A G, KOYAMA R, MARDINLY A R, YAMASAKl R, et al. Microglia sculpt postnatal neural circuits in an activity and complement- de-pendent manner [J]. Neuron, 2012, 74(4):691-705.
DU Changhong, LIU Yinping. Research progress in the pathogenesis of diabetic retinopathy [J]. Journal of Shenyang Medical College, 2023, 25(01):88-91.
XIAO Chunyu, LI Cunzi, TAO Hui, TANG Xianling. Targeted therapy for diabetic retinal neurodegeneration [J]. Journal of Clinical and Pathological Research, 2023, 43(12):2195-2200.
CUENCA N, FERNANDEZ-SANCHEZ L, CAMPELLO L, MA-NEU V, DE LA VILLA P, LAX P, et al. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases [J]. Prog Retin Eye Res, 2014, 43:17-75.
WU H. WANG M, LI X, SHAO Y. The metaflammatory and immunometabolic role of macrophages and microglia in diabetic retinopathy [J]. Hum Cell. 2021. 34(6). 1617-1628.
ZUO Xiangduo, LIU Xiaolan, DUAN Junhua, et al. Research progress on the mechanism of neurovascular unit damage in patients with diabetic retinopathy [J]. Shandong Medical Journal, 2023, 63(14):89-92.
Campochiaro PA. Molecular pathogenesis of retinal and choroidal vascular diseases [J]. Prog Retin Eye Res, 2015, 49:67-81.
Zahs KR, Ceelen PW. Gap junctional coupling and connexin immunoreactivity in rabbit retinal glia [J]. Vis Neurosci, 2006, 23(1):1-10.
ZHOU Sifeng, ZHU Jieyun, XU Haishu, NI Ying. Advances in mechanism on pigment epithelium derived factor in diabetes retinopathy [J]. Journal of Diagnostics Concepts & Practice, 2024, 23(02):192-201.
UNTERLAUFT J D, CLAUDEPIERRE T, SCHMIDT M, et al. Enhanced survival of retinal ganglion cells is mediated by Millerglial cell-derived PEDF [J]. Exp Eye Res, 2014, 127:206-214.
JIA F, HAN X H, LUAN L, et al. Effects of PEDF-MSCs on apoptosis of retinal ganglion cell in diabetic rats [J]. Acta Acad Med Weifang, 2019, 41(5):334-337.
Afarid M, Sanie-Jahromi F. Potential neuroprotective biomolecules in ophthalmology. Int Ophthalmol2021, 41(3):1103-1109.
An-Min Zhu, Wei Tan, Jiang-Ni Wu. Research progress on brain-derived neurotrophic factor in ocular diseases [J]. International Eye Science, 2022, 22(2):225-229.
Dan-Dan Liu, Guo-Tong Xu, Jing-Fa Zhang. Research progress of erythropoietin in the treatment of diabetic retinopathy [J]. International Eye Science, 2021, 21(9):1539-1542.
MADRAKHIMOV S B, YANG J Y, KM J H, HAN J W, PARK TK. mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy [J]. Cell Commun Signal, 2021, 19(1)29.
YANG An-Ping, CHEN Li-Ping, WU Xiao-Chun, et al. Pharmacoeconomic analysis of Compound Thrombokinase Capsules and calcium hydrogen sulfate for the treatment of diabetic retinopathy [J]. China Journal of Pharmaceutical Economics, 2017, 12(10):5-8, 94.
WU Liuqing, YANG Duo. Effect of Calcium Dobesilate Combined with Amiotide Eye Drops in the Treatment of Nonproliferative Diabetic Retinopathy [J]. CHINESE AND FOREIGN MEDICAL RESEARCH, 2024, 22(29):41-45.
WANG Chunyan, WANG Yongke, SUN Xijun. Effect of Calcium Isobenesulfonate Combined with Fundus Laser in the Treatment of Diabetic Retinopathy [J]. Diabetes New World Magazine, 2023, 26(18):176-178+186.
HUANG Yan-qing, XU Duan-lian, CAI You-mei, HUANG Li-juan. Clinical trial of calcium dobesilate capsules combined with ranibizumab in the treatment of macular edema of diabetic retinopathy [J]. The Chinese Journal of Clinical Pharmacology, 2018, 34(23):2707-2710.
Zhu Lin, Xu Yongsong, Feng Xiaotong, Zhao Dong, Ke Jing. Progresses in the drug treatment of diabetic retinopathy [J]. Journal of Capital Medical University, 2024, 45(03):438-445.
Zhang Ting, Zhang Xiaomeng. Research progress on the effect of panretinal photocoagulation on visual field in the treatment of diabetic retinopathy [J]. International Eye Science, 2024, 24(07):1093-1097.
Liu Xiaoling, Sun Zuhua. Appropriate use of laser photocoagulation and anti-vascular endothelial growth factor drugs, to treat the diabetie retinopathy effectively [J]. Chinese Journal of Ocular Fundus Diseases, 2020, 36(10):749-753.
Ke-Ke Hu, Yan-Nian Hui, Hong-Jun Du. Application progress of laser photocoagulation in diabetic retinopathy treatment in the era of anti-vascular endothelial growth factor agents [J]. International Eye Science, 2023, 23(08):1285-1289.
Mei Fu, Zuo-Hui-Zi Yi, Chang-Zheng Chen. Research progress of targeted retinal photocoagulation in the treatment of diabetic retinopathy [J]. International Eye Science, 2022, 22(4):579-582.
SHAO Yi, GE Qianmin, CHEN Xu. Specification on the fluocinolone acetonide treatment for patients with diabetic macular edema: interpretation of expert consensus 2023 [J]. Recent Advances in Ophthalmology, 2023, 43(10):757-760.
CHAI Yongxin, WEN Ying, BI Ailing. Recent advances in the treatment of diabetic macular edema by Traditional Chinese Medicine and Western Medicine [J]. China Journal of Chinese Ophthalmology, 2021, 31(09):668-672+679.
MU Xiaoying, LU Bo, DAI Xin, YANG Jing. Research progress of anti-vascular endothelial growth factor drugs in the treatment of diabetes retinopathy [J]. China Modern Medicine, 2024, 31(09):195-198.
Xu Dahua, Chen Mei. Current status and prospect of treatment of refractory diabetic macular edema [J]. Journal of Clinical Ophthalmology, 2023, 31(02):179-183.
Van Bergen T, Etienne I, Cunningham F, et al. The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases. Prog Retin Eye Res2019, 69:116-136.
Ming S, Xie K, Yang M, et al. Comparison of intravitreal dexamethasone implant and anti-VEGF drugs in the treatment of retinal vein occlusion-induced oedema: ameta-analysis and systematic review [J]. BMJ Open, 2020, 10(6):32128.
CHEN Minghao, LIU Peiyu, WANG Xuan, WU Yixiang, JIANG Yujin, ZHANG Chaoyang, ZHANG Jingfa. Advances in drug therapy of diabetic retinopathy [J]. Journal of Shanghai Jiao tong University: Medical Science, 2024, 44(07):822-829.
SUPE S, UPADHYA A, TRIPATHI S, DIGHE V, SINGH K. Li-posome-polyethylenimine complexes for the effective delivery of HuR siRNA in the treatment of diabetic retinopathy [J]. Drg Deliv Transl Res, 2023, 13(6):1675-1698.
ZHENG Bo, CHU Meifang, WANG Yong, et al. Relative property study of triamcinolone acetonide intravitreal and trans-tenon's retrobulbar injection treat retinal vein obstruction patients with macular edema [J]. International Eye Science, 2008, 8(8):1691-1693.
Theoretical Research and Clinical Efficacy Evaluation of Integrated Traditional Chinese and Western Medicine inthe Treatment of Diabetic Macular Edema [D]. China Academy of Chineses Medical Sciences, 2024.
MUSHTAQ Y, MUSHTAQ M M, GATZIOUFAS Z, et al. Intravitreal fuocinolone acetonide implant (ILUVIEN®) for the treatment of retinal conditions. a review of clinical studies1. Drug Des Devel Ther, 2023, 17:961-975.
ZHANG Jingfa. Role of inflammation in diabetic retinopathy: pathogenesis and treatment strategies [J]. Recent Advances in Ophthalmology, 2024, 44(01):1-12.
PINNA A, BLASETTI F, RICCI G D, BOSCIA F. Bromfenac eyedrops in the treatment of diabetic macular edema: a pilot study [J]. Eur J Ophthalmol, 2017, 27(3). 326-330.
Chao-Yang Zhang, Jing-Xiang Zhang, Jing-Fa Zhang. Application and prospect of gene therapy for fundus vascular diseases [J]. International Eye Science, 2023, 23(3):400-406.
GELFMAN C M, GRISHANIN R, BENDER K O, et al. Comprehensive preclinical assessment of ADVM-022, an intravitreal anti-VEGF gene therapy for the treatment of neovascular AMD and diabetic macular edema [J], J Ocul Pharmacol Ther, 2021, 37(3):181-190.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Furong Pan, Jingan Tong, Wang Pan, Yanrui Dong
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
